CTNNB1 and neoplasm: In patient OC05, a CTNNB1 pathogenic variant (c.110C>G) was identified in the plasma sample with a VAF of 0.8%, which was not detected previously in the tumor sample (right ovary; sequence coverage at the variant position: 4762 reads).